Targeting cytokine storm to manage patients with COVID-19: a mini-review

N Roshanravan, F Seif, A Ostadrahimi… - Archives of medical …, 2020 - Elsevier
Corona Virus Disease 2019 (COVID-19) pandemic is rapidly spreading all over the world.
Excessive immune responses trigger life-threatening cytokine release syndrome (CRS) …

[HTML][HTML] Calming the inflammatory storm in severe COVID-19 infections: Role of biologics-A narrative review

D Banji, SS Alqahtani, OJF Banji… - Saudi Pharmaceutical …, 2021 - Elsevier
The risk of Coronavirus infection continues, and the fear of resurgence indicates the lack of a
successful therapeutic strategy. In severe COVID-19 infection, many immune cells and their …

Role of inflammatory markers in corona virus disease (COVID-19) patients: a review

J Upadhyay, N Tiwari… - Experimental Biology and …, 2020 - journals.sagepub.com
The whole world is locked down due to the outbreak of novel Coronavirus Disease 2019
(nCOVID-19). A novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Plausibility of natural immunomodulators in the treatment of COVID-19–A comprehensive analysis and future recommendations

R Akter, MR Rahman, ZS Ahmed, A Afrose - Heliyon, 2023 - cell.com
The COVID-19 pandemic has inflicted millions of deaths worldwide. Despite the availability
of several vaccines and some special drugs approved for emergency use to prevent or treat …

[HTML][HTML] Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy

Y Shimizu - World journal of clinical cases, 2020 - ncbi.nlm.nih.gov
Although 80% of individuals infected with the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2) recover without antiviral treatments, the other 20% progress to …

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections

SR Bonam, NG Kotla, RA Bohara, Y Rochev… - Nano today, 2021 - Elsevier
Abstract COVID-19, coronavirus disease 2019, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this …

Chemotherapy vs. Immunotherapy in combating nCOVID19: An update

A Choudhury, G Mukherjee, S Mukherjee - Human Immunology, 2021 - Elsevier
The nCOVID-19 pandemic initiated its course of contagion from the city of Wuhan and now it
has spread all over the globe. SARS-CoV-2 is the causative virus and the infection as well …

Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

N Ebrahimi, S Aslani, F Babaie… - International …, 2020 - Elsevier
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) is responsible for recent
ongoing public health emergency in the world. Sharing structural and behavioral similarities …

Immunomodulators for curtailing COVID-19: a positive approach

SA Bhat, SA Rather, A Iqbal, HA Qureshi… - Journal of drug delivery …, 2020 - jddtonline.info
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is highly infectious,
spreading swiftly from man to man which has not been previously recognized in humans …

Calming the storm: natural immunosuppressants as adjuvants to target the cytokine storm in COVID-19

AE Peter, BV Sandeep, BG Rao… - Frontiers in …, 2021 - frontiersin.org
The COVID-19 pandemic has caused a global health crisis, with no specific antiviral to treat
the infection and the absence of a suitable vaccine to prevent it. While some individuals …